256 related articles for article (PubMed ID: 32370479)
1. [The role of three-dimensional speckle tracking imaging derived parameters on predicting outcome of hypertrophic cardiomyopathy patients with MYH7 mutations].
Zhao J; Wang J; Liu LW; Zheng Y; Wang B; Li WX; Yang F; Kang N; Zuo L
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):287-293. PubMed ID: 32370479
[No Abstract] [Full Text] [Related]
2. [Predicting value of 2014 European guidelines risk prediction model for sudden cardiac death (HCM Risk-SCD) in Chinese patients with hypertrophic cardiomyopathy].
Li WX; Liu LW; Wang J; Zuo L; Yang F; Kang N; Lei CH
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Dec; 45(12):1033-1038. PubMed ID: 29325362
[No Abstract] [Full Text] [Related]
3. Global longitudinal strain and left atrial volume index improve prediction of appropriate implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy patients.
Debonnaire P; Thijssen J; Leong DP; Joyce E; Katsanos S; Hoogslag GE; Schalij MJ; Atsma DE; Bax JJ; Delgado V; Marsan NA
Int J Cardiovasc Imaging; 2014 Mar; 30(3):549-58. PubMed ID: 24500241
[TBL] [Abstract][Full Text] [Related]
4. Association of variants in MYH7, MYBPC3 and TNNT2 with sudden cardiac death-related risk factors in Brazilian patients with hypertrophic cardiomyopathy.
Mori AA; Castro LR; Bortolin RH; Bastos GM; Oliveira VF; Ferreira GM; Hirata TDC; Fajardo CM; Sampaio MF; Moreira DAR; Pachón-Mateos JC; Correia EB; Sousa AGMR; Brión M; Carracedo A; Hirata RDC; Hirata MH
Forensic Sci Int Genet; 2021 May; 52():102478. PubMed ID: 33588347
[TBL] [Abstract][Full Text] [Related]
5. Global Longitudinal Strain and Left Atrial Volume Index Provide Incremental Prognostic Value in Patients With Hypertrophic Cardiomyopathy.
Hiemstra YL; Debonnaire P; Bootsma M; van Zwet EW; Delgado V; Schalij MJ; Atsma DE; Bax JJ; Marsan NA
Circ Cardiovasc Imaging; 2017 Jul; 10(7):. PubMed ID: 28679523
[TBL] [Abstract][Full Text] [Related]
6. Myocardial Deformation Analysis in
Höller V; Seebacher H; Zach D; Schwegel N; Ablasser K; Kolesnik E; Gollmer J; Waltl G; Rainer PP; Verheyen S; Zirlik A; Verheyen N
Genes (Basel); 2021 Sep; 12(10):. PubMed ID: 34680864
[TBL] [Abstract][Full Text] [Related]
7. Clinical features, spectrum of causal genetic mutations and outcome of hypertrophic cardiomyopathy in South Africans.
Ntusi NA; Shaboodien G; Badri M; Gumedze F; Mayosi BM
Cardiovasc J Afr; 2016; 27(3):152-158. PubMed ID: 27841901
[TBL] [Abstract][Full Text] [Related]
8. Prognostic predictive value of gene mutations in Japanese patients with hypertrophic cardiomyopathy.
Chida A; Inai K; Sato H; Shimada E; Nishizawa T; Shimada M; Furutani M; Furutani Y; Kawamura Y; Sugimoto M; Ishihara J; Fujiwara M; Soga T; Kawana M; Fuji S; Tateno S; Kuraishi K; Kogaki S; Nishimura M; Ayusawa M; Ichida F; Yamazawa H; Matsuoka R; Nonoyama S; Nakanishi T
Heart Vessels; 2017 Jun; 32(6):700-707. PubMed ID: 27885498
[TBL] [Abstract][Full Text] [Related]
9. Lack of Phenotypic Differences by Cardiovascular Magnetic Resonance Imaging in MYH7 (β-Myosin Heavy Chain)- Versus MYBPC3 (Myosin-Binding Protein C)-Related Hypertrophic Cardiomyopathy.
Weissler-Snir A; Hindieh W; Gruner C; Fourey D; Appelbaum E; Rowin E; Care M; Lesser JR; Haas TS; Udelson JE; Manning WJ; Olivotto I; Tomberli B; Maron BJ; Maron MS; Crean AM; Rakowski H; Chan RH
Circ Cardiovasc Imaging; 2017 Feb; 10(2):. PubMed ID: 28193612
[TBL] [Abstract][Full Text] [Related]
10. Long-Term Prevalence of Systolic Dysfunction in MYBPC3 Versus MYH7-Related Hypertrophic Cardiomyopathy.
Beltrami M; Fedele E; Fumagalli C; Mazzarotto F; Girolami F; Ferrantini C; Coppini R; Tofani L; Bertaccini B; Poggesi C; Olivotto I
Circ Genom Precis Med; 2023 Aug; 16(4):363-371. PubMed ID: 37409452
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals.
Sedaghat-Hamedani F; Kayvanpour E; Tugrul OF; Lai A; Amr A; Haas J; Proctor T; Ehlermann P; Jensen K; Katus HA; Meder B
Clin Res Cardiol; 2018 Jan; 107(1):30-41. PubMed ID: 28840316
[TBL] [Abstract][Full Text] [Related]
12. Family screening for hypertrophic cardiomyopathy: Is it time to change practice guidelines?
Lafreniere-Roula M; Bolkier Y; Zahavich L; Mathew J; George K; Wilson J; Stephenson EA; Benson LN; Manlhiot C; Mital S
Eur Heart J; 2019 Dec; 40(45):3672-3681. PubMed ID: 31170284
[TBL] [Abstract][Full Text] [Related]
13. 3D speckle tracking echocardiographic strain pattern in Hypertrophic Cardiomyopathy and its relation with Sudden Cardiac Death risk markers.
Rakesh K; Rajesh GN; Vellani H
Indian Heart J; 2021; 73(4):451-457. PubMed ID: 34474757
[TBL] [Abstract][Full Text] [Related]
14. The prognostic value of standardized reference values for speckle-tracking global longitudinal strain in hypertrophic cardiomyopathy.
Hartlage GR; Kim JH; Strickland PT; Cheng AC; Ghasemzadeh N; Pernetz MA; Clements SD; Williams BR
Int J Cardiovasc Imaging; 2015 Mar; 31(3):557-65. PubMed ID: 25585646
[TBL] [Abstract][Full Text] [Related]
15. Utility of genetics for risk stratification in pediatric hypertrophic cardiomyopathy.
Mathew J; Zahavich L; Lafreniere-Roula M; Wilson J; George K; Benson L; Bowdin S; Mital S
Clin Genet; 2018 Feb; 93(2):310-319. PubMed ID: 29053178
[TBL] [Abstract][Full Text] [Related]
16. Genetic determinants of clinical phenotype in hypertrophic cardiomyopathy.
Velicki L; Jakovljevic DG; Preveden A; Golubovic M; Bjelobrk M; Ilic A; Stojsic S; Barlocco F; Tafelmeier M; Okwose N; Tesic M; Brennan P; Popovic D; Ristic A; MacGowan GA; Filipovic N; Maier LS; Olivotto I
BMC Cardiovasc Disord; 2020 Dec; 20(1):516. PubMed ID: 33297970
[TBL] [Abstract][Full Text] [Related]
17. Hypertrophic cardiomyopathy clinical phenotype is independent of gene mutation and mutation dosage.
Viswanathan SK; Sanders HK; McNamara JW; Jagadeesan A; Jahangir A; Tajik AJ; Sadayappan S
PLoS One; 2017; 12(11):e0187948. PubMed ID: 29121657
[TBL] [Abstract][Full Text] [Related]
18. Predictive value of left atrial strain analysis in adverse clinical events in patients with hypertrophic cardiomyopathy: a CMR study.
Tian D; Zhang J; He Y; Xiong Z; Zhao M; Hu S; Song Q; Li Z
BMC Cardiovasc Disord; 2023 Jan; 23(1):42. PubMed ID: 36690952
[TBL] [Abstract][Full Text] [Related]
19. Incident Atrial Fibrillation Is Associated With MYH7 Sarcomeric Gene Variation in Hypertrophic Cardiomyopathy.
Lee SP; Ashley EA; Homburger J; Caleshu C; Green EM; Jacoby D; Colan SD; Arteaga-Fernández E; Day SM; Girolami F; Olivotto I; Michels M; Ho CY; Perez MV;
Circ Heart Fail; 2018 Sep; 11(9):e005191. PubMed ID: 30354366
[TBL] [Abstract][Full Text] [Related]
20. Echocardiographic characteristics of PRKAG2 syndrome: a research using three-dimensional speckle tracking echocardiography compared with sarcomeric hypertrophic cardiomyopathy.
Tang L; Li X; Zhou N; Jiang Y; Pan C; Shu X
Cardiovasc Ultrasound; 2022 May; 20(1):14. PubMed ID: 35509080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
